🇺🇸 FDA
Patent

US 7097835

Immunoselective targeting agents and methods of use thereof

granted A61KA61K47/6825A61K47/6843

Quick answer

US patent 7097835 (Immunoselective targeting agents and methods of use thereof) held by The Regents of the University of California expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K47/6825, A61K47/6843, A61K47/6849